---
kind: "unit"
title: "20"
title_heading: "Employees' Benefits"
key: "chII/subchB/part220"
level: "part"
label: "Part 220"
heading: "Determining Disability"
release: "ecfr-current"
date: "2026-08-27"
url: "https://uscodex.org/cfr/20/chII-subchB-part220"
sections_count: 97
---

# Part 220 — Determining Disability

Title 20 C.F.R. — Employees' Benefits › Chapter II — Railroad Retirement Board › Subchapter B — Regulations under the Railroad Retirement Act

## Contents

- [Subpart A — General](/cfr/20/chII-subchB-part220-subpartA.md)
- [Subpart B — General Definitions of Terms Used in This Part](/cfr/20/chII-subchB-part220-subpartB.md)
- [Subpart C — Disability Under the Railroad Retirement Act for Work in an Employee's Regular Railroad Occupation](/cfr/20/chII-subchB-part220-subpartC.md)
- [Subpart D — Disability Under the Railroad Retirement Act for Any Regular Employment](/cfr/20/chII-subchB-part220-subpartD.md)
- [Subpart E — Disability Determinations Governed by the Regulations of the Social Security Administration](/cfr/20/chII-subchB-part220-subpartE.md)
- [Subpart F — Evidence of Disability](/cfr/20/chII-subchB-part220-subpartF.md)
- [Subpart G — Consultative Examinations](/cfr/20/chII-subchB-part220-subpartG.md)
- [Subpart H — Evaluation of Disability](/cfr/20/chII-subchB-part220-subpartH.md)
- [Subpart I — Medical Considerations](/cfr/20/chII-subchB-part220-subpartI.md)
- [Subpart J — Residual Functional Capacity](/cfr/20/chII-subchB-part220-subpartJ.md)
- [Subpart K — Vocational Considerations](/cfr/20/chII-subchB-part220-subpartK.md)
- [Subpart L — Substantial Gainful Activity](/cfr/20/chII-subchB-part220-subpartL.md)
- [Subpart M — Disability Annuity Earnings Restrictions](/cfr/20/chII-subchB-part220-subpartM.md)
- [Subpart N — Trial Work Period and Reentitlement Period for Annuitants Disabled for Any Regular Employment](/cfr/20/chII-subchB-part220-subpartN.md)
- [Subpart O — Continuing or Stopping Disability Due to Substantial Gainful Activity or Medical Improvement](/cfr/20/chII-subchB-part220-subpartO.md)